Valsartan and Neurogenic bladder - a phase IV clinical study of FDA data

Summary:

Neurogenic bladder is reported as a side effect among people who take Valsartan (valsartan), especially for people who are male, 40-49 old, have been taking the drug for 2 - 5 years also take Lipitor, and have High blood cholesterol.

The phase IV clinical study analyzes which people have Neurogenic bladder when taking Valsartan. It is created by eHealthMe based on reports of 62,763 people who have side effects when taking Valsartan from the FDA, and is updated regularly.

What is Valsartan?

Valsartan has active ingredients of valsartan. It is often used in high blood pressure. eHealthMe is studying from 63,805 Valsartan users. Check the latest studies of Valsartan.

What is Neurogenic bladder?

Neurogenic bladder (the normal function of the bladder is to store and empty urine in a coordinated, controlled fashion) is found to be associated with 467 drugs and 570 conditions by eHealthMe. Check the latest studies of Neurogenic bladder.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 25, 2026

62,763 people reported to have side effects when taking Valsartan.
Among them, 12 people (0.02%) have Neurogenic bladder.

Could Valsartan cause Neurogenic bladder?

Among these 12 people:

How long have people been on Valsartan when they have Neurogenic bladder? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 100 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Neurogenic bladder when taking Valsartan? *

  • female: 41.67 %
  • male: 58.33 %

What is the age of people who have Neurogenic bladder when taking Valsartan? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 66.67 %
  • 50-59: 33.33 %
  • 60+: 0.0 %

What are other drugs people take besides Valsartan? *

  1. Lipitor: 6 people, 50.00%
  2. Zopiclone: 2 people, 16.67%
  3. Ativan: 2 people, 16.67%
  4. Iclusig: 2 people, 16.67%
  5. Doxepin Hydrochloride: 1 person, 8.33%
  6. Alprazolam: 1 person, 8.33%
  7. Amlodipine Besylate: 1 person, 8.33%
  8. Ammonium Lactate: 1 person, 8.33%
  9. Ampyra: 1 person, 8.33%
  10. Avonex: 1 person, 8.33%

What are other side effects people have besides Neurogenic bladder? *

  1. Gait Disturbance: 7 people, 58.33%
  2. Acute Kidney Failure: 7 people, 58.33%
  3. Penile Ulceration: 6 people, 50.00%
  4. Scrotal Ulcer: 6 people, 50.00%
  5. Gamma-Glutamyltransferase Abnormal: 6 people, 50.00%
  6. Metabolic Acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body): 6 people, 50.00%
  7. Diabetic Nephropathy (diabetic kidney disease): 6 people, 50.00%
  8. Nephropathy (damage to or disease of a kidney): 6 people, 50.00%
  9. Neurosis (a class of functional mental disorders involving distress but neither delusions nor hallucinations): 6 people, 50.00%
  10. Diabetic Hyperosmolar Coma (diabetes coma due to extremely high blood sugar (glucose) levels; extreme lack of water (dehydration)): 6 people, 50.00%

What are the existing conditions these people have? *

  1. High Blood Cholesterol: 5 people, 41.67%
  2. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 16.67%
  3. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 2 people, 16.67%
  4. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 8.33%
  5. Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Valsartan and have Neurogenic bladder?

- Check whether Neurogenic bladder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Valsartan:

Neurogenic bladder treatments and more:

How severe was Neurogenic bladder and when was it recovered:

Expand to all the drugs that have ingredients of valsartan:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Valsartan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Neurogenic bladder:

Browse all the conditions that are associated with Neurogenic bladder:


How the study uses the data?

The study uses data from the FDA. It is based on valsartan (the active ingredients of Valsartan) and Valsartan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: